Toshiba America Medical Systems recently showcased new Aplio Platinum Series CV ultrasound systems, designed to deliver superior cardiac diagnoses at the patient’s side. The Aplio 500 Platinum CV and Aplio300 Platinum CV feature 2D Wall Motion Tracking, spectral and color Doppler, and the company’s latest suite of guidance and workflow technologies.
“To successfully implement strain imaging into our laboratory schedule, we needed an echo system that can image a broad range of patients and is easy to use,” said Edmund K. Kerut, MD, of West Jefferson Medical Center. “Toshiba’s Aplio 500 Platinum CV with Wall Motion Tracking technology delivers the image quality and data we need for quantitative measurements. It has made it easier to perform calculation of LV volumes with ejection fraction and serial follow-up of our chemotherapy patients with added GLS measurements.”
According to Toshiba, the Aplio 500 Platinum CV and Aplio 300 Platinum CV offers excellent definition of the endocardium, which results in an accurate and user-friendly 2D strain resolution. The company’s Wall Motion Tracking technology enables clinicians to quantify isolated movement within the heart to assist with detection of cardiotoxicity.
“The common perception is that implementing strain imaging into routine cardiac ultrasound increases exam times,” added Curt Hanawalt, sonographer, West Jefferson Medical Center. “However, with Toshiba’s Wall Motion Tracking we are able to measure EF and strain using the same protocol. The technology has actually helped us reduce exam times, providing a shorter and more comfortable experience for the patient.”
Get AXIS e-newsletters free. Subscribe here.
